Difference between revisions of "Team:UCSC"
| Line 59: | Line 59: | ||
<div class="column_body"> | <div class="column_body"> | ||
| − | |||
<a href="https://2018.igem.org/Team:UCSC/Team"><img src="https://static.igem.org/mediawiki/2018/e/e3/T--UCSC--teamImage2.png" alt="Team Image" style="width:50%" class="image_box"></a> | <a href="https://2018.igem.org/Team:UCSC/Team"><img src="https://static.igem.org/mediawiki/2018/e/e3/T--UCSC--teamImage2.png" alt="Team Image" style="width:50%" class="image_box"></a> | ||
| − | |||
| − | |||
| − | |||
| − | |||
</div> | </div> | ||
| + | |||
<div class="column_body"> | <div class="column_body"> | ||
<a href="https://2018.igem.org/Team:UCSC"><img src="https://static.igem.org/mediawiki/2018/e/e4/T--UCSC--Info2.png" alt="Info Image" style="width:50%"></a> | <a href="https://2018.igem.org/Team:UCSC"><img src="https://static.igem.org/mediawiki/2018/e/e4/T--UCSC--Info2.png" alt="Info Image" style="width:50%"></a> | ||
Revision as of 21:44, 27 June 2018
iGEM Project 2018
The UCSC iGEM team project for 2018 will be to produce steroid hormones in yeast: specifically progesterone. Progesterone is a hormone that the female body naturally produces that can suppress ovulation. The right to control one’s own fertility is a basic human right. Regretfully though, in 2014 it was estimated that 225 million women worldwide aged 15-49 years had unmet need for contraception. These numbers are abysmal and we hope that we can help change that.
There is a lack of access to family planning services for women across the globe.
The ability to pursue an education, sports, a career… all start with the luxury to choose when, and if, to begin a family.
Progesterone is a hormone naturally produced by women, and can be used to suppress ovulation and act as a form of contraception.
Y. lipolytica is a GRAS organism that has an advanced genetic toolbox and can be easily grown in most environments.
We will engineer Y. lipolytica to produce progesterone; our hope is to localize contraception production and increase availability in developing nations.
